Navigating Key Complexities in the Development of Cell and Gene Therapies
Discover how biotech organizations navigate the unique challenges of cell and gene therapies, from regulatory shifts to recruitment and market uncertainty.
Site
Full Board vs Expedited vs Exempt: Why IRBs do That
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Is Your Site Ready for an FDA Inspection?
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
How to Optimize Your sIRB Experience
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Rare and Orphan Diseases in Regulated Development
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Why Now is the Right Time to Adopt eConsent
eConsent streamlines trial participation, allowing remote access and minimizing paperwork errors, benefitting both research staff and participants alike.
Budget Negotiation 101
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Onboarding & Training for Clinical Research Professionals
In this webinar, Miranda Schramm, Director of Training at Advarra, covers strategies for new hires joining the clinical trial industry.
Empowering Patients Through Education and Advocacy in Cancer Care
In the evolving landscape of healthcare, the role of the patient has shifted from a passive recipient of care
Didn’t Expect That to Happen: Events That Must be Reported Promptly to the IRB
Learn what events need to be reported to the IRB after study approval and explore scenarios to help evaluate potentially reportable events.
The Role of Data in Optimizing Clinical Trials: Key Insights for Sites and Sponsors
In the fast-evolving landscape of clinical research, data collection and performance metrics are indispensable tools for enhancing the efficiency
How Sites Can Win in the New Age of Genetically Engineered Treatments
With gene therapy trials on the rise, sites must prepare biosafety protocols, facility standards, and partnerships to attract cutting-edge studies.